Loading PGNY…
Loading financial statements…
Import this data to Google Sheets with:
=jivedata("PGNY","financials")Full statements spill as a table. For one cell: =jivedata("PGNY","Revenue") or =jivedata("PGNY","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.
PGNY • CIK 0001551306
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Revenue from Contract with Customer, Excluding Assessed Tax | $1,088,598 | $1,167,221 | $1,288,661 | $1,310,764 |
| Cost of Goods and Services Sold | $849,799 | $913,858 | $984,177 | $988,676 |
| Gross Profit | $238,799 | $253,363 | $304,484 | $322,088 |
| Operating Income (Loss) | $62,184 | $67,455 | $85,277 | $112,131 |
| Other Nonoperating Income (Expense) | $5,203 | $15,747 | $10,155 | $7,707 |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $70,691 | $83,202 | $95,432 | $119,838 |
| Income Tax Expense (Benefit) | $8,654 | $28,866 | $36,912 | $41,205 |
| Net Income (Loss) Attributable to Parent | $62,037 | $54,336 | $58,520 | $78,633 |
| Weighted Average Number of Shares Outstanding, Basic | 95,021,175 | 91,481,995 | 85,651,721 | 79,536,199 |
| Weighted Average Number of Shares Outstanding, Diluted | 100,672,399 | 95,448,357 | 89,861,843 | 83,830,383 |
| Selling and Marketing Expense | $59,488 | $63,948 | $72,113 | $70,880 |
| General and Administrative Expense | $117,127 | $121,960 | $147,094 | $139,077 |
| Operating Expenses | $176,615 | $185,908 | $219,207 | $209,957 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Cash and Cash Equivalents, at Carrying Value | $97,296 | $162,314 | $112,238 | $152,632 |
| Debt Securities, Available-for-sale, Current | $273,791 | $65,640 | $197,858 | $84,293 |
| Property, Plant and Equipment, Net | $10,213 | $12,383 | $29,927 | $41,992 |
| Accounts Receivable, after Allowance for Credit Loss, Current | $241,869 | $235,324 | $220,287 | $257,476 |
| Operating Lease, Right-of-Use Asset | $17,605 | $17,251 | $24,990 | $23,577 |
| Prepaid Expense and Other Assets, Current | $27,451 | $9,443 | $21,392 | $18,617 |
| Goodwill | $11,880 | $15,534 | $19,978 | $19,853 |
| Assets, Current | $640,407 | $472,721 | $551,775 | $513,018 |
| Finite-Lived Intangible Assets, Net | $0 | $1,303 | $6,216 | $5,748 |
| Deferred Income Tax Assets, Net | $73,120 | $84,933 | $93,013 | $93,077 |
| Other Assets, Noncurrent | $3,395 | $2,977 | $16,536 | $18,571 |
| Assets | $756,620 | $607,102 | $742,435 | $715,836 |
| Operating Lease, Liability, Noncurrent | $17,241 | $16,413 | $24,000 | $22,495 |
| Liabilities | $203,191 | $185,040 | $226,391 | $262,579 |
| Accounts Payable, Current | $125,426 | $95,097 | $124,071 | $152,050 |
| Liabilities, Current | $185,950 | $168,627 | $202,391 | $240,084 |
| Common Stock, Value, Issued | $9 | $9 | $9 | $9 |
| Additional Paid in Capital, Common Stock | $461,639 | $581,596 | $700,785 | $735,417 |
| Treasury Stock, Common, Value | $1,009 | $303,889 | $388,075 | $537,525 |
| Retained Earnings (Accumulated Deficit) | $89,971 | $144,307 | $202,827 | $255,111 |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | $2,819 | $39 | $498 | $245 |
| Stockholders' Equity Attributable to Parent | $553,429 | $422,062 | $516,044 | $453,257 |
| Accounts Receivable, Allowance for Credit Loss | $46,636 | $56,355 | $55,659 | $54,735 |
| Common Stock, Shares Authorized | 1,000,000,000 | 1,000,000,000 | 1,000,000,000 | 1,000,000,000 |
| Common Stock, Shares, Issued | 96,348,522 | 97,692,891 | 99,049,485 | 99,774,414 |
| Common Stock, Shares, Outstanding | 96,348,522 | 85,310,698 | 83,365,696 | 77,390,288 |
| Treasury Stock, Common, Shares | 615,980 | 12,998,173 | 16,299,769 | 23,000,106 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $62,037 | $54,336 | $58,520 | $78,633 |
| Net Cash Provided by (Used in) Operating Activities | $188,814 | $179,105 | $210,192 | $201,248 |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | $62 | $-92 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $-22,782 | $65,018 | $-48,121 | $17,061 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $97,296 | $162,314 | $114,193 | $133,525 |
| Cash and Cash Equivalents, at Carrying Value | $97,296 | $162,314 | $112,238 | $134,606 |
| Restricted Cash and Cash Equivalents | — | — | $1,955 | $1,955 |
| Deferred Income Taxes and Tax Credits | $3,745 | $-10,456 | $-8,115 | $-8,118 |
| Payments to Acquire Property, Plant, and Equipment | $3,644 | $5,405 | $18,410 | $22,864 |
| Payments to Acquire Debt Securities, Available-for-sale | $429,694 | $170,339 | $354,964 | $154,876 |
| Depreciation, Depletion and Amortization | $2,281 | $3,175 | $4,948 | $5,741 |
| Proceeds from Sale of Debt Securities, Available-for-sale | $232,813 | $376,840 | $223,701 | $243,398 |
| Gain (Loss) on Disposition of Property Plant Equipment | — | $-1,414 | $-79 | $-580 |
| Payments to Acquire Businesses, Net of Cash Acquired | — | $5,304 | $9,340 | $0 |
| Share-based Payment Arrangement, Noncash Expense | $122,611 | $128,130 | $131,867 | $107,171 |
| Net Cash Provided by (Used in) Investing Activities | $-200,525 | $195,792 | $-159,013 | $65,658 |
| Accounts Receivable, Credit Loss Expense (Reversal) | $19,934 | $16,396 | $20,526 | $19,685 |
| Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss | $4,328 | $2,115 | $866 | $327 |
| Foreign Currency Transaction Gain (Loss), before Tax | $8 | $0 | $0 | $0 |
| Payments for Repurchase of Common Stock | — | $300,278 | $81,657 | $230,287 |
| Proceeds from Stock Options Exercised | $4,850 | $1,099 | $86 | $99 |
| Payments of Debt Issuance Costs | — | — | $3,087 | $3,087 |
| Payment, Tax Withholding, Share-based Payment Arrangement | $17,200 | $12,001 | $15,848 | $17,200 |
| Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised | $1,278 | $1,300 | $1,144 | $1,250 |
| Net Cash Provided by (Used in) Financing Activities | $-11,072 | $-309,880 | $-99,362 | $-249,753 |
| Income Taxes Paid, Net | $6,181 | $40,449 | $55,490 | $50,129 |
| Capital Expenditures Incurred but Not yet Paid | $421 | $249 | $681 | $2,329 |
| Increase (Decrease) in Accounts Receivable | $21,738 | $9,874 | $5,117 | $5,339 |
| Increase (Decrease) in Prepaid Expense and Other Assets | $22,930 | $-18,018 | $11,947 | $193 |
| Increase (Decrease) in Accounts Payable | $16,235 | $-30,268 | $28,752 | $11,388 |
| Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | $10,361 | $9,924 | $417 | $2,544 |
| Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net | $-648 | $-425 | $9,306 | $11,388 |